|
|
Volumn 2012, Issue , 2012, Pages 115-121
|
|
Initial choice of therapy among plenty for newly diagnosed chronic myeloid leukemia.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 METHYL N (3 (4 METHYLIMIDAZOL 1 YL) 5 (TRIFLUOROMETHYL)PHENYL) 3 ((4 PYRIDIN 3 YLPYRIMIDIN 2 YL)AMINO)BENZAMIDE;
4-METHYL-N-(3-(4-METHYLIMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-3-((4-PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO)BENZAMIDE;
ALPHA INTERFERON;
ANILINE DERIVATIVE;
BENZAMIDE DERIVATIVE;
BOSUTINIB;
DASATINIB;
IMATINIB;
NITRILE;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
QUINOLINE DERIVATIVE;
THIAZOLE DERIVATIVE;
ALLOTRANSPLANTATION;
CHRONIC MYELOID LEUKEMIA;
HUMAN;
METABOLISM;
METHODOLOGY;
ONCOLOGY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
ANILINE COMPOUNDS;
BENZAMIDES;
HUMANS;
INTERFERON-ALPHA;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
MEDICAL ONCOLOGY;
NITRILES;
PIPERAZINES;
PYRIMIDINES;
QUINOLINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
STEM CELL TRANSPLANTATION;
THIAZOLES;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 84877739735
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation.v2012.1.115.3798209 Document Type: Review |
|
Times cited : (26)
|
|
References (0)
|
